Private equity firms circle Australia’s Healthscope

Australian private healthcare provider Healthscope is considering buy-out offers from two more bidders, including more private equity firms, as competition for the company heats up.

  • 31 May 2010

Two new bidders have made offers valuing the company at A$5.80 a share, or A$1.84bn ($1.56bn) in total, Healthscope announced on Monday.

KKR is among the new bidders, potentially in partnership with CVC. The other bidder is understood to be US private healthcare group Tenet Healthcare.

The two bids ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 15.35
2 Rabobank 14.41
3 Morgan Stanley 11.73
4 Barclays 8.99
5 Credit Agricole 7.57

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Feb 2017
1 Wells Fargo Securities 11,897.40 33 11.83%
2 Bank of America Merrill Lynch 9,837.56 29 9.78%
3 Citi 9,714.54 32 9.66%
4 JPMorgan 7,997.38 24 7.95%
5 Credit Suisse 6,335.67 14 6.30%